BISTTRY07:30Live
ONCSM Balance Sheet and Financial StatementsOncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
95.650.00 (0.00%)
- Previous close
- 95.65
- Market cap
- TRY 2.3B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for ONCSM is 2026/6. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. (ONCSM), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/6 | 238.5M | 87.8M | 25.1M |
| 2026/3 | 239M | 72M | 5.9M |
| 2025/12 | 185.7M | 108.2M | 33.8M |
| 2025/9 | 71.7M | 28.5M | 14.8M |
| 2025/6 | 283.9M | 34.3M | 898.5K |
Frequently Asked Questions
How much profit did ONCSM report in its latest statements?
In the latest period (2026/6) ONCSM reported a net profit of TRY 25.1M, sales of TRY 238.5M and EBITDA of TRY 87.8M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.